[Tickers Inside] 7 Solid Gainers Over the Last 5 Sessions

Stocks with 5 days of consecutive price advances. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [Tech Billionaires Embrace Nuclear-Powered Future]( [See What's Going On Today With Uranium and the Nuclear Sector]( --------------------------------------------------------------- December 12, 2022 From the desk of the Editor (5 Day Gainers Report) Dear Reader, We just identified 7 Five Day Gainers across all US Exchanges. If you are interested in any of these companies, we encourage you to do your own research and due diligence. Keep reading to see what we just uncovered... --------------------------------------------------------------- Sponsor Message [Elon Musk and Bill Gates Agree On Nuclear Energy?]( Elon Musk to Bill Gates to politicians on both sides of the aisle, powerful people are now backing the expanded use of nuclear energy. They believe that safe, advanced nuclear technologies will play a vital role in our clean energy transition. Unfortunately, we're far too dependent on Russia for our uranium supply. That's why we desperately need more DOMESTIC sources of the yellow metal that fuels nuclear reactors. [See Why Uranium Should Now Be On Every Investor's Radar]( --------------------------------------------------------------- [NeuroOne Medical Technologies, NMTC]( Recent Analyst Action: Ben Haynor, analyst at Alliance Global Partners, reiterates coverage on [NeuroOne Medical Technologies (NMTC)](in the Healthcare sector with a Buy rating and a price target of $3.25 (1 month ago). - Recent Price: $2.87 - Average Analyst Price Target: $3.25 (13.24%) - Market Cap: $45.71M [TipRanks.com]( also reports that [NeuroOne Medical Technologies](currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $3.25. The target pricing ranges from a high forecast of $3.25 down to a low forecast of $3.25. [NeuroOne Medical Technologies (NMTC)](’s last closing price was $2.87 which would put the average price target at $3.25. Here are 3rd party ratings for [NMTC](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: n/a, n/a [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [3 Billionaires Have Already Invested in My No. 1 Fear-to-Fortune Stock]( Billionaires are taking advantage of market turmoil by investing heavily into my favorite “fear-to-fortune” stock. It’s a secret used by investors like Warren Buffett, David Tepper and Sir John Templeton to become filthy rich. [How it works is simple…]( --------------------------------------------------------------- [ICLICK INTERACTIVE ASIA GROUP, ICLK]( Recent Analyst Action: Nelson Cheung, analyst at Citigroup, reiterates coverage on [ICLICK INTERACTIVE ASIA GROUP (ICLK)](in the Services sector with a Buy rating and a price target of $3.5 (1 week ago). - Recent Price: $4.23 - Average Analyst Price Target: $3.50 (-17.26%) - Market Cap: $40.77M [TipRanks.com]( also reports that [ICLICK INTERACTIVE ASIA GROUP](currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $3.50. The target pricing ranges from a high forecast of $3.50 down to a low forecast of $3.50. [ICLICK INTERACTIVE ASIA GROUP (ICLK)](’s last closing price was $4.23 which would put the average price target at $3.50. Here are 3rd party ratings for [ICLK](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: n/a, n/a [Click here for chart >>]( -------------------------------------------------------------------------- [Aerovate Therapeutics, AVTE]( Recent Analyst Action: Andreas Argyrides, analyst at Wedbush, reiterates coverage on [Aerovate Therapeutics (AVTE)](in the Healthcare sector with a Buy rating and a price target of $54.00 (10 hours ago). - Recent Price: $27.9 - Average Analyst Price Target: $40.50 (45.16%) - Market Cap: $609.96M [TipRanks.com]( also reports that [Aerovate Therapeutics](currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $40.50. The target pricing ranges from a high forecast of $54.00 down to a low forecast of $27.00. [Aerovate Therapeutics (AVTE)](’s last closing price was $27.9 which would put the average price target at $40.50. Here are 3rd party ratings for [AVTE](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Sell, Top 22% (56 out of 249) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [These 2 Dividend Stocks Pay Every Week]( you still looking for consistent income in this near-zero interest rate environment? There is a better way. I just revealed the Holy Grail of dividend stocks - a safe, reliable and consistent stock that [pays dividends EVERY single week](- 52 times a year. It's simple: Buy the stock this Monday and you'll get your first dividend payout in your bank account this Thursday....and then every Thursday after for as long as you own the stock! [Tap here to reveal the name of this stock for FREE.]( --------------------------------------------------------------- [Delcath Systems, DCTH]( Recent Analyst Action: William Maughan, analyst at Canaccord Genuity, reiterates coverage on [Delcath Systems (DCTH)](in the Healthcare sector with a Buy rating and a price target of $14.00 (3 weeks ago). - Recent Price: $3.61 - Average Analyst Price Target: $17.33 (380.06%) - Market Cap: $31.55M [TipRanks.com]( also reports that [Delcath Systems](currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $17.33. The target pricing ranges from a high forecast of $19.00 down to a low forecast of $14.00. [Delcath Systems (DCTH)](’s last closing price was $3.61 which would put the average price target at $17.33. Here are 3rd party ratings for [DCTH](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Hold, Top 38% (94 out of 249) [Click here for chart >>]( -------------------------------------------------------------------------- [TELA Bio, TELA]( Recent Analyst Action: David Turkaly, analyst at JMP Securities, reiterates coverage on [TELA Bio (TELA)](in the Healthcare sector with a Buy rating and a price target of $20.00 (1 month ago). - Recent Price: $10.87 - Average Analyst Price Target: $17.50 (60.99%) - Market Cap: $197.34M [TipRanks.com]( also reports that [TELA Bio](currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $17.50. The target pricing ranges from a high forecast of $20.00 down to a low forecast of $15.00. [TELA Bio (TELA)](’s last closing price was $10.87 which would put the average price target at $17.50. Here are 3rd party ratings for [TELA](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: buy - Zacks.com: Sell, Top 22% (56 out of 249) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [The Biggest "Missing Ingredient" in the $7 Trillion EV Market]( has owned the graphite market for decades. But the U.S. just added graphite to a list of super-critical minerals... "essential for America's National Defense." Perfect timing for a "made in America" graphite company looking to mine, manufacture, and recycle graphite for the booming electric car market. [Don't Miss Your Opportunity to Benefit from This Breaking News]( --------------------------------------------------------------- [Nyxoah, NYXH]( Recent Analyst Action: Adam Maeder, analyst at Piper Sandler, reiterates coverage on [Nyxoah (NYXH)](in the Healthcare sector with a Buy rating and a price target of $13.00 (1 month ago). - Recent Price: $5.84 - Average Analyst Price Target: $19.61 (235.78%) - Market Cap: $154.06M [TipRanks.com]( also reports that [Nyxoah](currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $19.61. The target pricing ranges from a high forecast of $31.00 down to a low forecast of $13.00. [Nyxoah (NYXH)](’s last closing price was $5.84 which would put the average price target at $19.61. Here are 3rd party ratings for [NYXH](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: Hold, Bottom 43% (142 out of 249) [Click here for chart >>]( -------------------------------------------------------------------------- [Samsara, IOT]( Recent Analyst Action: Alex Zukin, analyst at Wolfe Research, reiterates coverage on [Samsara (IOT)](in the Technology sector with a Buy rating and a price target of $15.00 (1 week ago). - Recent Price: $13.88 - Average Analyst Price Target: $20.40 (46.97%) - Market Cap: $6.78B [TipRanks.com]( also reports that [Samsara](currently has 6 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $20.40. The target pricing ranges from a high forecast of $40.00 down to a low forecast of $15.00. [Samsara (IOT)](’s last closing price was $13.88 which would put the average price target at $20.40. Here are 3rd party ratings for [IOT](: - TipRanks.com: Strong Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Hold, Top 24% (59 out of 249) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Will This Jumpstart a New Uranium Boom Market?]( in the early 2000's, Paladin Energy was the darling of the last uranium boom when it shot up from ten cents to over nine dollars. Today's uranium supply/demand imbalance has a lot in common with the last market cycle. Combined with a strong comeback for nuclear energy, this could be setting the stage for the next uranium boom. [Get the Full Story on Uranium Opportunities Here]( --------------------------------------------------------------- And there you have it--7 Five Day Gainers across all US Exchanges. Sincerely, The Editor, MarketTickerPress.com Market Ticker Press Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. By opening and/or clicking a link containted within this email, you are reconfirming your opt-in status. You can unsubscribe at any time. MarketTickerPress.com part of Sandpiper Marketing Group | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | North Carolina | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software